Dr. Michael Joseph Mulligan, MD

Dr. Mulligan practices at Surgery Center Mountain View in Mountain View, California.

Dr. Mulligan's NPI, 1306884283, was assigned on June 3, 2006. Dr. Mulligan graduated from UC San Diego School of Medicine in 1986. Dr. Mulligan holds California license G62916.

Dr. Mulligan's primary practice is Surgery Center Mountain View, at 701 E. El Camino Real, 1 Northwest, Mountain View, CA 94040. The practice phone is (408) 739-6000.

Dr. Mulligan's primary practice is Surgery Center Mountain View in Mountain View, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Mulligan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mulligan practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Mulligan's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Mulligan is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Mulligan is licensed in California.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Mulligan treats.

CMS data shows 2,007 Medicare services from Dr. Mulligan across 10 procedure codes in 2024, for 265 Medicare patients. Medicare paid $53,266 for them. Every service was in an office.

CMS counts 265 Medicare patients who saw Dr. Mulligan in 2024. The largest group is 65 to 74, with 147 patients. 67% of them have high cholesterol, and 62% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mulligan's median patient age at 39, with 51% women.

In 2024, Dr. Mulligan wrote 1,255 Medicare Part D claims for 187 patients. 59% of them were for generic drugs. CMS names the drug for 1,105 of them, across 34 drugs with 11 or more claims each, at $465,797 in total drug cost. In 2023, CMS named 1,000 claims across 30 drugs.

Dr. Mulligan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mulligan as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Mulligan from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 56% of the total. CSL Behring paid the most, $71.

Dmand AI lists 2 awards for Dr. Mulligan, most recently CMS Stage 1 EHR in 2013.

Dr. Mulligan graduated from UC San Diego School of Medicine in 1986. Dr. Mulligan is a member of AAAAI.

Dr. Mulligan is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.